PL
PL · PL · PL-100477939
Skyrizi
ATC L04AC18
Last synced from URPL (Poland) on
Identification
ManufacturerAbbVie Deutschland GmbH & Co. KG
CountryPL (PL)
ATC codeL04AC18
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin08054083025179
- gtin04150180650239
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "600 mg",
"packaging": "08054083025179 ¦ Rpz ¦ EU/1/19/1361/004 ¦ 150059\n1 fiol. 10 ml\n¦ UR/Z/4c/001/24 - 04150180650239 ¦ UR/Z/4c/307/25 - 04150180650239",
"substance": "Risankizumabum 60 mg/ml",
"common_name": "Risankizumabum",
"pl_product_id": "100477939",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L04AC18.
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
Access this data programmatically
Query Skyrizi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.